Pharma Archives - Page 77 of 81 - Life Sciences Times

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

October 9, 2025

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

October 7, 2025

RevBio Awarded $2.2 Million NIH Grant to Advance Minimally Invasive Use of TETRANITE® for Treating Spine Fractures

October 6, 2025

THIS WEEK'S STORIES

Vensana Capital Launches Vensana Innovation, Appoints Thomas Tu, M.D., as Venture Partner and CEO

October 7, 2025

Bristol Myers Squibb and TV Host Gail Simmons Launch Initiative to Reduce Stigma and Build Support for People Living with Schizophrenia

October 10, 2025

Stoke Therapeutics and Biogen Report Long-Term Data Supporting Zorevunersen’s Potential as a Disease-Modifying Therapy for Dravet Syndrome

October 10, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

Prilenia and Ferrer Present New Data Highlighting Pridopidine’s Sustained Benefits in Huntington’s Disease at 2025 HSG Congress

Stoke Therapeutics and Biogen Report Long-Term Data Supporting Zorevunersen’s Potential as a Disease-Modifying Therapy for Dravet Syndrome

Kernal Bio Secures Up to $48 Million from ARPA-H to Advance In Vivo CAR T-Cell Therapies for Cancer and Autoimmune Disease

Astria Therapeutics Launches Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart for Hereditary Angioedema

FDA Approves Genentech’s Tecentriq Plus Lurbinectedin as First-Line Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer

Most Read

Bristol Myers Squibb and TV Host Gail Simmons Launch Initiative to Reduce Stigma and Build Support for People Living with Schizophrenia

Urban Green Council Honors Suffolk Chairman and CEO John Fish for Leadership in Sustainable Building

Pulse Biosciences Reports Positive First-in-Human Results for nPulse Cardiac Surgical System at European Cardio-Thoracic Surgery Meeting

Tilak Healthcare Secures Reimbursement for Odysight, the First Remote Ophthalmology Monitoring Solution, Under France’s PECAN Program

EDITOR PICKS

Perceptive Imaging Names Doug Fulling as CEO to Lead Next Phase of Growth and Innovation

Affinia Therapeutics Raises $40 Million Series C to Advance Next-Generation Gene Therapies for Cardiovascular and Neurological Diseases

RevBio Awarded $2.2 Million NIH Grant to Advance Minimally Invasive Use of TETRANITE® for Treating Spine Fractures

THIS WEEK'S STORIES

Vensana Capital Launches Vensana Innovation, Appoints Thomas Tu, M.D., as Venture Partner and CEO

Bristol Myers Squibb and TV Host Gail Simmons Launch Initiative to Reduce Stigma and Build Support for People Living with Schizophrenia

Stoke Therapeutics and Biogen Report Long-Term Data Supporting Zorevunersen’s Potential as a Disease-Modifying Therapy for Dravet Syndrome

POPULAR CATEGORY

ABOUT US

FOLLOW US